| __timestamp | Amicus Therapeutics, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 1893422000 |
| Thursday, January 1, 2015 | 76943000 | 2012800000 |
| Friday, January 1, 2016 | 104793000 | 1973300000 |
| Sunday, January 1, 2017 | 149310000 | 2253600000 |
| Monday, January 1, 2018 | 270902000 | 2597200000 |
| Tuesday, January 1, 2019 | 286378000 | 2280600000 |
| Wednesday, January 1, 2020 | 308443000 | 3990900000 |
| Friday, January 1, 2021 | 272049000 | 2501200000 |
| Saturday, January 1, 2022 | 276677000 | 2231100000 |
| Sunday, January 1, 2023 | 152381000 | 2702600000 |
| Monday, January 1, 2024 | 2041800000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Biogen Inc. and Amicus Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Biogen consistently outspent Amicus by a significant margin, with its R&D expenses peaking at nearly $4 billion in 2020, a year marked by global health challenges. In contrast, Amicus's highest R&D expenditure was approximately $308 million in the same year, reflecting a more conservative investment strategy.
Despite the disparity, both companies have shown a steady increase in their R&D budgets, with Biogen's spending growing by about 43% and Amicus's by over 500% from 2014 to 2023. This trend underscores the critical role of R&D in driving innovation and maintaining a competitive edge in the biotech industry.
Merck & Co., Inc. vs Biogen Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Biogen Inc. or Insmed Incorporated: Who Invests More in Innovation?
Research and Development Investment: Biogen Inc. vs United Therapeutics Corporation
Research and Development Expenses Breakdown: Biogen Inc. vs Madrigal Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.